Prednisolone Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Once Weekly Infant Corticosteroid Trial for DMD
Condition:   Duchenne Muscular Dystrophy Intervention:   Drug: Prednisolone Sponsors:   Anne M. Connolly;   Ann& Robert H Lurie Children's Hospital of Chicago;   Children's Hospital Medical Center, Cincinnati Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2022 Category: Research Source Type: clinical trials

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)
Condition:   Lymphoma, Large B-Cell, Diffuse Interventions:   Biological: Zilovertamab Vedotin;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Biological: Rituximab;   Biological: Rituximab Biosimilar;   Drug: Prednisone;   Drug: Prednisolone Sponsor:   Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2022 Category: Research Source Type: clinical trials